BioCryst Pharmaceuticals, Inc.BCRXNASDAQ
Loading
Cash generated from core business operations
Latest
$330.93M
↑ 720% vs avg
Percentile
P100
Near historical high
Streak
3 yr
Consecutive growthExpanding
Average
$-53.42M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $330.93M | +736.2% |
| 2024 | $-52.02M | +45.3% |
| 2023 | $-95.14M | +41.2% |
| 2022 | $-161.85M | -13.9% |
| 2021 | $-142.16M | -3.6% |
| 2020 | $-137.22M | -53.2% |
| 2019 | $-89.58M | +3.2% |
| 2018 | $-92.56M | -125.0% |
| 2017 | $-41.14M | +23.0% |
| 2016 | $-53.44M | - |